Director, Commercial Finance - Deciphera Pharmaceuticals

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines.

Enabled by our proprietary drug discovery platform, Deciphera has developed a diverse pipeline of wholly-owned drug candidates. QINLOCK® (ripretinib) is Deciphera’s switch control inhibitor developed for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Switzerland, Taiwan, the United States, and the United Kingdom.  We wholly own QINLOCK and all of our drug candidates with the exception of a development and commercialization out-license agreement for QINLOCK in Greater China. In addition to QINLOCK, we have identified and advanced multiple product candidates from our platform into clinical studies, including vimseltinib and DCC-3116.  

See here for more details on our portfolio.

Deciphera is seeking a Director, Commercial Finance to be based in Waltham MA, the company’s headquarters. The Director, Commercial Finance will lead the company’s Commercial Finance function to support the company’s first product on the market, QINLOCK and prepare for multiple product launches planned over the next several years.  This is a high-profile position that provides the opportunity to work with senior leadership across the organization.

The successful candidate will have experience in bio-pharmaceutical industry. S/he will possess strong leadership, management, and communication skills.

This position reports to the Senior Director, Corporate Controller.

Key Responsibilities:

• Strategic Finance partner to Commercial organization providing financial leadership, guidance and insight including; Revenue recognition and tracking against covering analysts, gross to net accounting and financial reporting of monthly/quarterly results of Commercial group Op Ex
• Prepare and deliver key analysis and presentations to leadership and the Board.
• Lead efforts to build the Company’s capability to provide revenue guidance and report against such guidance by Day 3 of the close
• Partner with Accounting and Commercial counterparts on all aspects of Revenue Reporting. Includes working with multiple data systems, reviewing sales orders to determine gross-to-net assumptions (government rebate programs, returns reserve and other adjustment to revenue).
• Collaborate with Commercial functional areas on key strategic areas including pricing dynamics and contract administration.
• Drive timely results to internal and external customers and partners
• Collaborate with a multidisciplinary team on S&OP process to ensure alignment of sales plan resulting in an uninterrupted supply.
• Identify and lead special projects and analysis that provide a strategic, financial, and analytical approach to decision making. Advocate for continuous improvement initiatives.

• Bachelor’s degree.
• At least 12 years of relevant work experience.
• Strong knowledge of the pharmaceutical business including drug development and commercialization.
• Proven track record of successfully developing and implementing “right-sized” processes.
• Strong strategic thinking and problem-solving skills, including ability to develop strategic frameworks to facilitate decision making around complex opportunities.
• Flexibility and ability to leverage ad hoc financial opportunities and innovative thinking to adapt to rapidly evolving situations and fulfill challenging timelines.
• Strong analytical & financial modeling skills (product forecasts, P&L, NPV models, etc.).
• Experience leading and motivating cross-functional teams, and ability to deliver on project timelines, progress, and outcomes in small company/startup environments.
• Excellent communications skills, in writing and orally, including presentation to senior executives and board.
• Strong technology skills, including proficiency in the Microsoft Office Suite.

We offer an outstanding culture and opportunity for personal and professional growth guided by our “PATHS” Core Values and how we work together. We are proud to be Great Place to Work Certified 2023 and rank #25 on Fortune’s Best Places to Work Small and Midsized Biotech Companies in 2023. Find more details about our award-winning culture here. 

Deciphera offers a comprehensive benefits package that includes but is not limited to the following:

• Non-accrual paid time off
• Summer vacation bonus
• Global, company-wide summer and winter shutdowns
• An annual lifestyle allowance
• Monthly cell phone stipend
• Internal rewards and recognition program
• Medical, Dental, and Vision Insurance
• 401(k) retirement plan with company match
• Life and Supplemental life insurance for family
• Short and Long Term Disability insurance
• ESPP offering
• Health savings account with company contribution
• Flexible spending account for either health care and/or dependent care.
• Family planning benefit
• Generous parental leave
• [if applicable] Car allowance

Deciphera (NASDAQ: DCPH) is a publicly traded company headquartered in Waltham, Massachusetts. Our state-of-the-art research facility is located in Lawrence, Kansas and our European operations are run out of Switzerland.

EQUAL EMPLOYMENT OPPORTUNITY INFORMATION

Deciphera is committed to equal employment opportunity and values diversity. To ensure that we comply with reporting requirements and to learn more about how we can increase diversity in our candidate pool, we invite you to voluntarily provide demographic information in a confidential survey at the end of this application. Providing this information is optional. It will not be accessible or used in the hiring process, and has no effect on your opportunity for employment. This information will also be treated confidentially.  Our commitment to increasing diversity in our candidate pool does not affect our commitment to equal employment opportunity, including our ongoing commitment to make all hiring and other employment decisions solely on a nondiscriminatory basis.